JY
CELGZ

Jeff Yass’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Jeff Yass’s Portfolio CELGZ Stock Details CELGZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-75,435
Closed -$47K – 11311
2019
Q2 		$47K Buy
75,435
+472
+0.6% +$339 ﹤0.01% 9855
2019
Q1 		$81K Sell
74,963
-35,498
-32% -$34.7K ﹤0.01% 8327
2018
Q4 		$50K Buy
+110,461
New +$101K ﹤0.01% 8485
2018
Q3 		– Sell
-31,196
Closed -$11K – 10930
2018
Q2 		$11K Buy
31,196
+17,715
+131% +$5.33K ﹤0.01% 9466
2018
Q1 		$5K Sell
13,481
-16,246
-55% -$10.6K ﹤0.01% 9200
2017
Q4 		$29K Buy
+29,727
New +$34.1K ﹤0.01% 9031
2016
Q4 		– Sell
-15,486
Closed -$16K – 10649
2016
Q3 		$16K Sell
15,486
-343
-2% -$414 ﹤0.01% 8265
2016
Q2 		$23K Buy
+15,829
New +$20.4K ﹤0.01% 8366

Other funds holding CELGZ

DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
FA
FCG Advisors Chatham, New Jersey $425M AUM 12.09% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
BFA
Beaumont Financial Advisors Needham, Massachusetts $1.57B AUM 25.77% 1-Year Est. Return
TPA
Trivium Point Advisory Westport, Connecticut $1.1B AUM 28.81% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jeff Yass's CELGZ Position: Q3 2019 in Review

Jeff Yass sold out of Celgene Corporation Contingent Value Rights (CELGZ) in Q3 2019, closing a stake of 75,435 shares — an estimated $47K sold.

Jeff Yass first reported a position in CELGZ in Q2 2016 and held it in 8 quarters. The position peaked at $81K in Q1 2019. 24 funds tracked by Wall St. Rank hold CELGZ as of Q3 2019.

  • Jeff Yass reported no remaining Celgene Corporation Contingent Value Rights position as of Q3 2019 after selling out during the quarter.
  • Jeff Yass sold 75,435 Celgene Corporation Contingent Value Rights shares in Q3 2019, an estimated $47K.
  • Jeff Yass first reported a position in Celgene Corporation Contingent Value Rights in Q2 2016 and held it in 8 quarters.
  • Jeff Yass's Celgene Corporation Contingent Value Rights position peaked at $81K in Q1 2019.
  • 24 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q3 2019.

Based on Susquehanna International Group's 13F filing for Q3 2019, filed 14 Nov 2019.